A Phase 1 Study of BST02 in Treating Locally Advanced Liver Cancer

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 4, 2024

Primary Completion Date

July 3, 2025

Study Completion Date

December 3, 2025

Conditions

Locally Advanced Liver Carcinoma

Interventions

BIOLOGICAL

BST02

BST02 is a tumor infiltrating lymphocyte product manufactured from the sample collected in the patient's tumor lesion.

Trial Locations (1)

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors

lead

BioSyngen Pte Ltd

INDUSTRY

NCT06526832 - A Phase 1 Study of BST02 in Treating Locally Advanced Liver Cancer | Biotech Hunter | Biotech Hunter